Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

Ensitrelvir, an oral inhibitor of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) 3C-like protease, is approved in Japan for the treatment of mild-to-moderate coronavirus disease 2019 ...

A study in Current Microbiology found higher antibiotic resistance genes in the noses and throats of Covid-19 patients. The ...

New research has identified a novel series of SARS-CoV-2 Mpro inhibitors that may lead to potential new COVID-19 treatments that, according to preclinical testing, effectively inhibits COVID-19 and ...

A multi-institutional study led by researchers at the University of Alabama at Birmingham and the University of North Carolina at Chapel Hill has revealed a previously underappreciated mechanism by ...

WASHINGTON — A War Department program requested proposals for so-called “gain of function” experiments that could make ...

Five years ago, on March 11, 2020, the World Health Organization declared COVID-19 a pandemic. Whether it still is depends on who you ask. There are no clear criteria to mark the end of a pandemic, ...

During the first few years of the COVID-19 pandemic, the virus SARS-CoV-2 was detected in an increasing number of non-human animal species. This included many wild animal species as well as domestic ...

Experts say that along with Covid-19, there is also a rise in influenza, adenoviruses, and rhinoviruses, which has led to a ...

According to Dr. Vishnuvardhan, Director of Medical Education, the World Health Organization (WHO) is monitoring the RF.5 ...